It is easy to use—A tube of blood is inserted and the result is automatically displayed within 10 minutes, making it the first test suitable to use in a clinical setting, even in the cath lab. It is ...
Nov. 14, 2005 — The U.S. Food and Drug Administration (FDA) has approved a real-time cardiopulmonary resuscitation monitoring and feedback device to assist responders in providing appropriate ...
Portola Pharmaceuticals Announces that Phase 2 INNOVATE-PCI Trial with Elinogrel Achieved Objectives
STOCKHOLM, Sweden (August 30, 2010) - Portola Pharmaceuticals, Inc. today announced results from the Phase 2 INNOVATE-PCI study of its investigational antiplatelet drug, elinogrel, the only ...
Please provide your email address to receive an email when new articles are posted on . A possible association between the use of prasugrel, an ADP P2Y12 antagonist, and increased risk for cancer is ...
Please provide your email address to receive an email when new articles are posted on . The antithrombotic benefit of adding clopidogrel to aspirin therapy has been demonstrated by large multicenter, ...
Novartis AG to Pay Portola Pharmaceuticals, Inc. $75 Million for Anti-clotting Drug; Portola to Receive $500 Million in Potential Milestone Payments Plus Royalties on Future Sales SOUTH SAN FRANCISCO, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback